FDA approves olaparib/abiraterone combination for BRCA+ metastatic castration-resistant prostate cancer
The FDA has approved olaparib (Lynparza) plus abiraterone and prednisone or prednisolone for the treatment of patients with deleterious or […]
The FDA has approved olaparib (Lynparza) plus abiraterone and prednisone or prednisolone for the treatment of patients with deleterious or […]
The federal government is reconsidering a decision that breast cancer patients, plastic surgeons and members of Congress have protested would
Transcription: Kristie L.Kahl: After receiving a diagnosis, why is it important for patients to understand its benefits? What should they
Great news for those researching new treatments for depression in cancer patients! Positive long-term follow-up data has just been released
A LIFE-CHANGING cancer drug launched on the NHS thanks to money raised by brilliant Sun readers over 20 years ago.
Widespread cancer drug shortages are forcing doctors to make difficult decisions about how to treat their patients, including dose rationing